Digital Health Platform (DHP) to Deliver Mindfulness as a Stress Management Intervention Leveraging Electronic (SMILE) Health Records for Racial and Ethnic Populations During the COVID-19 Pandemic: Clinical Trial
Sponsor: University of North Carolina, Chapel Hill
Trial Details
| Condition | Anxiety, COVID-19 Pandemic |
| Intervention | Mindfulness |
| Phase | NA |
| Status | Terminated |
| Participants | 398 |
| Est. Completion | 27 May 2025 |
| Last Updated | 14 May 2026 |
Primary Outcome
Change From Baseline to Post-Intervention in the Generalized Anxiety Disorder-7 Scale; Change From Baseline to Follow-up in the Generalized Anxiety Disorder-7 Scale
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * self-identify as African American, Black, Hispanic and/or Latino * demonstrate symptoms of anxiety, as determined based on the GAD-7 screening measure (score between 8-14) Exclusion Criteria: * Current, or history of, heart disease * History of stroke or dementia * Diagnosis of movement disorders, such as Parkinson's Disease, or paralysis * Diagnosis of genetic disorders, such as Down Syndrome or Fragile-X syndrome * Diagnosis of autism * Diagnosis of schizophrenia, psychosis, dissociative disorder, mania/bipolar disorder, major depression or a personality disorder * History of serious mental or behavioral health problems requiring a hospital or treatment center stay within the past 12 months * Taking cardiac medications (other than blood pressure medications) * Taking seizure medications * Currently taking opioids medications or supplements * Practice of formal mindfulness for more than 15 minutes/day for 4 or more days/week over the past 6 months * GAD score \<8 or \>14
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service